Drug Type Small molecule drug |
Synonyms VZHE-039 |
Target |
Mechanism Sickle haemoglobin inhibitors(Sickle haemoglobin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H13NO4 |
InChIKeyXLXXLEASSCTIPV-UHFFFAOYSA-N |
CAS Registry2613439-36-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | US | 02 Dec 2016 |